XEL
41
4
MPC
36
-2
TJX
55
2
ORCL
37
4
HRL
35
12
CF
41
-7
STZ
48
6
EA
44
-3
DHR
68
2
GOOG
59
2
OXY
42
2
BWA
55
2
GME
68
-5
TROW
62
6
URI
49
3
AVGO
35
-19
BRK.B
40
7
USB
68
2
CMS
60
2
M
53
-5
XEL
41
4
MPC
36
-2
TJX
55
2
ORCL
37
4
HRL
35
12
CF
41
-7
STZ
48
6
EA
44
-3
DHR
68
2
GOOG
59
2
OXY
42
2
BWA
55
2
GME
68
-5
TROW
62
6
URI
49
3
AVGO
35
-19
BRK.B
40
7
USB
68
2
CMS
60
2
M
53
-5
Financhill
Back

CrossingBridge Pre-Merger SPAC ETF Vs. Lyell Immunopharma, Inc. Industry Stock Comparison

Sell
9

SPC
CrossingBridge Pre-Merger SPAC ETF

Last Price:
$21.80
Seasonality Move:
-1.19%
Buy
64

LYEL
Lyell Immunopharma, Inc.

Last Price:
$37.17
Seasonality Move:
-16.78%
Sell
9
CrossingBridge Pre-Merger SPAC ETF (SPC) is a Sell

Is CrossingBridge Pre-Merger SPAC ETF a Buy, Sell or Hold?

  • The current CrossingBridge Pre-Merger SPAC ETF [SPC] share price is $21.46. The Score for SPC is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
  • SPC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
64
Lyell Immunopharma, Inc. (LYEL) is a Buy

Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?

  • The current Lyell Immunopharma, Inc. [LYEL] share price is $37.37. The Score for LYEL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • LYEL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SPC Stock Price Chart

What is CrossingBridge Pre-Merger SPAC ETF's stock price today?

  • The CrossingBridge Pre-Merger SPAC ETF share price today is $21.46
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPC is experiencing slight selling pressure.

LYEL Stock Price Chart

What is Lyell Immunopharma, Inc.'s stock price today?

  • The Lyell Immunopharma, Inc. share price today is $37.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing slight selling pressure.

SPC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.8 Buy
Relative Strength Index (14 RSI): 39.64 Sell
Chaikin Money Flow: -215 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.56 - 21.92) Sell
Bollinger Bands (100): (21.54 - 21.88) Sell

LYEL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.08 Buy
Relative Strength Index (14 RSI): 79.16 Buy
Chaikin Money Flow: -97373 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.11 - 32.35) Buy
Bollinger Bands (100): (10.77 - 23.75) Buy

SPC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.58 Sell
20-day SMA: 21.68 Sell
50-day SMA: 21.82 Sell
200-day SMA: 21.42 Buy
8-day EMA: 13.67 Buy
20-day EMA: 7.12 Buy
50-day EMA: 3.19 Buy
200-day EMA: 0.85 Buy

LYEL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.51 Buy
20-day SMA: 28.33 Buy
50-day SMA: 21.67 Buy
200-day SMA: 13.52 Buy
8-day EMA: 33.02 Buy
20-day EMA: 28.99 Buy
50-day EMA: 23.45 Buy
200-day EMA: 17.42 Buy

CrossingBridge Pre-Merger SPAC ETF Earnings Growth & SPC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.

CrossingBridge Pre-Merger SPAC ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lyell Immunopharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):